Authors



Prethy Rao, MD, MPH

Latest:

Key Takeaways on Managing Neovascular AMD and DME

Nathan Steinle, MD; Adrienne Scott, MD; Carl Regillo, MD, FACS, FASRS; and Prethy Rao, MD, MPH, share final thoughts on the changing treatment landscape of neovascular AMD and DME.


Omar R. Shakir, MD, MBA

Latest:

Office vitrectomy: A full-scale replacement for the ASC and hospital

We stand on the cusp of a new era in vitreoretinal surgery, one that has been marked by only a select few seminal innovations


Dante Pieramici, MD

Latest:

Advancements in ocular drug delivery

Options empower patients and providers to decrease treatment burden


Lee MacMorris

Latest:

OCT: First 2D image by Adolf Fercher paved the way for today’s imaging technique

In the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.



Priya Sharma Vakharia, MD

Latest:

Knowing when the diamond-dusted membrane scraper is (and isn’t) the right tool

Revisiting a classic tool that still gets you out of a jam works best when you understand its powers and limitations.


Ajay V. Srivastava, MD, FACC

Latest:

Listening to the heart: Lessons from cardiology in remote monitoring and AI

Rather than speculating in a vacuum about the future of remote monitoring in ophthalmology, it is better to explore how other specialties in medicine adopted and integrated remote monitoring into their care plan frameworks.


David Chin-Yee, MD

Latest:

Reducing site burden and expanding research capacity with AI

How artificial intelligence could enhance clinical trials.


Adam M. Katz, MD

Latest:

Dexamethasone rebuttal: Who should perform intravitreal injections?

In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.


Tarek S. Hassan, MD

Latest:

New retinotomy technique reduces retinal surgery complications, improves recovery

Ophthalmologist Tarek Hassan introduces new surgical approach for proliferative vitreoretinopathy, using precise small retinotomies instead of extensive retinal removal to improve patient outcomes.


Sibylle Scholtz, PhD

Latest:

OCT: First 2D image by Adolf Fercher paved the way for today’s imaging technique

In the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.


Jose Agustin Martinez, MD, FASRS

Latest:

Significance of periphery in diabetic retinopathy diagnosis and management

Being able to visualize and evaluate the retinal periphery provides a better understanding of the disease status and supports a better treatment decision.


Matt Starr, MD

Latest:

Q&A: Matthew Starr, MD, shares his experience using scleral suture toric intraocular lenses for patients with significant corneal astigmatism

Matthew Starr, MD, discusses techniques for correcting astigmatism in patients lacking capsular support, enhancing visual outcomes surgery.


Lotfi Merabet, OD, PhD

Latest:

CVI definition: A work in progress

Working definition forwarded by NIH CVI Working Group


Caroline Richards

Latest:

2023: What awaits ophthalmology in the year ahead

As we approach the end of 2022, members of the Ophthalmology Times Europe® Editorial Advisory Board were asked to predict developments in their ophthalmic specialties and interests. A focus is our ageing population, while efficiency and productivity are also on their minds. The board members agree that one of the major challenges in the year to come will be the large number of patients awaiting diagnosis and treatment, which is only going to increase with the rising average life expectancy worldwide.


Ruth Hogg, PhD

Latest:

Ruth Hogg, PhD, on what retinal imaging can tell clinicians about the brain and body

With detailed imaging and cognitive data, the Northern Ireland Cohort for the Longitudinal Study of Aging highlights the potential of integrating eye scans into broader health research.


Matthew Roe, MD, MHS

Latest:

Big data: Driving opportunity for real-world evidence

Evidence-based medicine can lead to personalized care, better results for patients



Xiaoming Liu, PhD

Latest:

Enhanced OCT GA segmentation achieved with new multistage model

Researchers introduce a multistage dual-branch network to improve accuracy and efficiency.


Jayanth Sridhar, MD

Latest:

Practice perspective: Academic retina

A window into the world of academic retina practice today.


Achim Langenbucher, PhD

Latest:

OCT: First 2D image by Adolf Fercher paved the way for today’s imaging technique

In the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.


Ramin Tadayoni, MD, PhD

Latest:

Discussing worldwide pathological myopia

Dr. Ramin Tadayoni discusses the myopia panel at the EURETINA 2021 virtual meeting.


Dilraj S. Grewal, MD, FASRS

Latest:

Advancing ocular pharmacotherapy through the suprachoroidal space

Insights on injection technique and the future potential of SCS treatments.


Quan Dong Nguyen, MD, MSc, FARVO, FASRS

Latest:

Ultra-widefield imaging: A critical step in uveitis diagnosis and management

A multifaceted evaluation that includes ultra-widefield imaging can reveal new information and influence treatment decisions.


Hannah El-Sabrout

Latest:

The future of retina: New targets and more durable solutions

Among the promising areas of retinal disease research are innovative approaches targeting pan-vascular endothelial growth factor inhibition.


David Tanzer, MD

Latest:

David Tanzer, MD, CMO of Lexitas reflects on Retina World Congress

Lexitas Pharma Services' CMO discusses groundbreaking ophthalmology conference, emphasizing innovative clinical trials, emerging treatments for eye diseases, and the potential for transformative patient care strategies.


Brian K. Do, MD

Latest:

Expanding our vision of steroid-eluting implants

How long-term intravitreal steroid technology fits into a modern clinic.


Allen C. Ho, MD, FACS, FASRS

Latest:

Optogenetics for retinal disease

A mutation-agnostic gene therapy approach offers new possibilities for patients with advanced retinal disease.


Marco Mura, MD

Latest:

Adapting medical retina service in COVID-19 era requires careful approach

Minimizing clinic visits, maximizing use of imaging modalities are key

© 2025 MJH Life Sciences

All rights reserved.